Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in &ITMannheimia haemolytica&IT in calves at high risk of developing bovine respiratory disease

被引:24
|
作者
Crosby, S. [1 ]
Credille, B. [1 ]
Giguere, S. [2 ]
Berghaus, R. [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Food Anim Hlth & Management Program, Athens, GA 30602 USA
[2] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA
关键词
antimicrobial resistance; bovine respiratory disease; enrofloxacin; Mannheimia haemolytica; tulathromycin; EPITHELIAL LINING FLUID; FEEDLOT CATTLE; LUNG-TISSUE; MANNHEIMIA-HAEMOLYTICA; STOCKER CATTLE; PHARMACOKINETICS; TILMICOSIN; DRUG; PHARMACODYNAMICS; METAANALYSIS;
D O I
10.1093/jas/sky054
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Bovine respiratory disease (BRD) is the most common cause of morbidity and mortality in North American beef cattle. Mannheimia haemolytica is the bacterial pathogen most often isolated from cattle with BRD, and the prevalence of antimicrobial resistance (AMR) in this organism has increased in recent years. Antimicrobials are commonly used to prevent BRD in cattle at high risk of developing BRD; however, recent work would suggest that this practice might be one factor contributing to the increased prevalence of AMR in M. haemolytica. We hypothesized that the administration of the short-acting fluoroquinolone, enrofloxacin, would be just as effective as the long-acting triamilide, tulathromycin, in preventing BRD but would be less likely to select for AMR M. haemolytica in stocker calves at high risk of developing BRD. Three hundred forty-one stocker calves were enrolled in the study with 172 calves in 4 pens being randomly assigned to treatment with enrofloxacin and 169 calves in 4 pens randomly assigned to treatment with tulathromycin. Calves within each treatment group were allocated to one of 4 replicate pens based on the week of enrollment. Of calves receiving enrofloxacin, 33.7% required treatment for BRD at least once within 45 d after arrival, compared with 18.3% of calves receiving tulathromycin (P = 0.040). The percentages of calves that required more than one treatment for BRD within 45 d after arrival did not differ statistically for those receiving enrofloxacin compared with those receiving tulathromycin (10.5% and 4.7%, respectively; P = 0.107) Likewise, the percentages of calves that died during the 45-d follow-up period did not differ for those receiving enrofloxacin compared with those receiving tulathromycin (12.2% and 10.1%, respectively; P = 0.592). Mannheimia haemolytica was cultured from 11% of calves sampled at arrival and from 50% of calves sampled at revaccination 14 to 17 d later. There was a significanst effect of sampling time on the proportion of calves carrying multidrug-resistant (MDR) isolates, with calves having a higher prevalence of MDR isolates at revaccination than arrival (100% vs. 13%; P < 0.001). Future research evaluating the impact of MDR on response to antimicrobial therapy is necessary.
引用
收藏
页码:1259 / 1267
页数:9
相关论文
共 50 条
  • [1] Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease
    Torres, Siddartha
    Thomson, Dan U.
    Bello, Nora M.
    Nosky, Bruce J.
    Reinhardt, Chris D.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2013, 74 (06) : 839 - 846
  • [2] Longitudinal effects of enrofloxacin or tulathromycin use in preweaned calves at high risk of bovine respiratory disease on the shedding of antimicrobial-resistant fecal Escherichia coli
    Pereira, R., V
    Altier, C.
    Siler, J. D.
    Mann, S.
    Jordan, D.
    Warnick, L. D.
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (11) : 10547 - 10559
  • [3] Serotyping and antimicrobial resistance of Mannheimia haemolytica strains from European cattle with bovine respiratory disease
    Andres-Lasheras, Sara
    Zaheer, Rahat
    Klima, Cassidy
    Sanderson, Haley
    Polo, Rodrigo Ortega
    Milani, Mohammad Reza Marami
    Vertenten, Geert
    McAllister, Tim A.
    RESEARCH IN VETERINARY SCIENCE, 2019, 124 : 10 - 12
  • [4] Bovine respiratory disease: Efficacy of different prophylactic treatments in veal calves and antimicrobial resistance of isolated Pasteurellaceae
    Rerat, M.
    Albini, S.
    Jaquier, V.
    Huessy, D.
    PREVENTIVE VETERINARY MEDICINE, 2012, 103 (04) : 265 - 273
  • [5] Field Efficacy Study of Gamithromycin for the Control of Bovine Respiratory Disease in Cattle at High Risk of Developing the Disease
    Lechtenberg, Kelly
    Daniels, C. Scanlon
    Royer, Gregory C.
    Bechtol, David T.
    Chester, S. Ted
    Blair, Jeff
    Tessman, Ronald K.
    INTERNATIONAL JOURNAL OF APPLIED RESEARCH IN VETERINARY MEDICINE, 2011, 9 (02): : 184 - 192
  • [6] Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease How Are They Changing in Response to Efforts to Control Them?
    Snyder, Emily
    Credille, Brent
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2020, 36 (02) : 253 - +
  • [7] A literature review of antimicrobial resistance in Pathogens associated with bovine respiratory disease
    DeDonder, K. D.
    Apley, M. D.
    ANIMAL HEALTH RESEARCH REVIEWS, 2015, 16 (02) : 125 - 134
  • [8] Antimicrobial resistance in bovine respiratory disease: Auction market- and ranch-raised calves
    Wennekamp, Trent R.
    Waldner, Cheryl L.
    Windeyer, M. Claire
    Larson, Kathy
    Trokhymchuk, Anatoliy
    Campbell, John R.
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2022, 63 (01): : 47 - 54
  • [9] Association between respiratory disease pathogens in calves near feedlot arrival with treatment for bovine respiratory disease and subsequent antimicrobial resistance status
    Abi Younes, Jennifer N.
    Campbell, John R.
    Gow, Sheryl P.
    Woolums, Amelia R.
    Waldner, Cheryl L.
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [10] Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves
    Mzyk, Danielle A.
    Bublitz, Claire M.
    Martinez, Marilyn N.
    Davis, Jennifer L.
    Baynes, Ronald E.
    Smith, Geof W.
    PLOS ONE, 2019, 14 (06):